Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics

Andisheh Abedini, Annette Plesner, Ping Cao, Zachary Ridgway, Jinghua Zhang, Ling Hsien Tu, Chris T. Middleton, Brian Chao, Daniel J. Sartori, Fanling Meng, Hui Wang, Amy G. Wong, Martin T. Zanni, C. Bruce Verchere, Daniel P. Raleigh, Ann Marie Schmidt